热卖商品
新闻详情
Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular A...
来自 : 道客巴巴
发布时间：2021-03-24
![](\"http://static.doc88.com/assets/images/icons/type/PDF.png\"){kind=icon}
Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrill.2015年10月8日Dr. Tanahashi has received consultancy fees from Bayer and Mitsubishi Tanabe, and honoraria from Mitsubishi Tanabe and Sanofi-Aventis. Dr. G...Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation for the Secondary Prevention of Stroke A SRivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation for the Secondary Prevention of Stroke A S
本文链接： http://mitsubishitanabe.immuno-online.com/view-693264.html
发布于 ： 2021-03-24
阅读（0）
最新动态
2021-03-24
2021-03-24
2021-03-24
2021-03-24
2021-03-24
2021-03-24
2021-03-24
2021-03-24
2021-03-24
2021-03-24
2021-03-24
2021-03-24
公司介绍
品牌分类
联络我们
